AzTrials
AzTrials

Cancer SurvivorshipNCT07446595

BfedBwell INSPIRE Pilot

A study testing BfedBwell - Core Curriculum, BfedBwell - 1:1 Counseling and BfedBwell - Behavioral Skills in people with Cancer Survivorship and Overweight , Obesity, run by University of Colorado, Denver at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This single-arm pilot study will evaluate the feasibility and acceptability of a comprehensive survivorship lifestyle intervention addressing nutrition, exercise, sleep health, and stress management. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Cancer Survivorship, Overweight , Obesity
What is being tested?
BfedBwell - Core Curriculum, BfedBwell - 1:1 Counseling and BfedBwell - Behavioral Skills
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
11 Aug 2026to Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18-75 years
  • BMI 25-45 kg/m2
  • History of cancer within the past 10 years with a diagnosis of an adulthood cancer of any type
  • In maintenance or surveillance status, defined as completion of active cancer therapy (e.g., surgery, radiation, chemotherapy, immunotherapy) with curative intent at least 3 months and no more than 10 years prior to enrollment or active surveillance with no treatment; ongoing targeted or hormone therapies ≥3 months prior to intervention start date and/or ongoing maintenance therapy ≥1 year is permitted (exceptions to this timeframe for completion of other therapies can be made on a case-by-case basis by the PI if patients are tolerating therapy without adverse effects and will have completed active treatment or been in stable maintenance treatment prior to the intervention start date)
  • Have a primary care provider (or are willing to establish care with a primary care provider prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions and who will provide clearance to participate in a nutrition and exercise program
  • Ability and willingness to participate in a supervised exercise program; with ability assessed by the Physical Activity Readiness Questionnaire (PAR-Q+) and questions based upon National Comprehensive Cancer Network (NCCN) guidelines (note: any positive responses will trigger a required physician clearance form)
Show all 16Show fewer
  • Speak English
  • Have access to a computer or smart phone and Internet to join Zoom meetings, complete questionnaires, and access/download the True Coach virtual exercise coaching sessions
  • Live or work within 30 miles of the AHWC (exceptions may be made at the discretion of the study PI on a case-by-case basis for highly motivated subjects)
  • Not be planning for major elective surgery, to travel for >2 consecutive weeks, or relocate/move during the intervention (~6 months)
  • No nicotine or tobacco use within previous 6 months
  • Agree to refrain from use of all nutritional supplements aside from those prescribed by a physician for the duration of the study
  • Capable and willing to give informed consent and understand exclusion criteria
  • Willing to attend weekly small group education sessions, monthly behavioral skills development sessions, weekly group support sessions, and monthly 1:1 counseling sessions with a registered dietitian (RD)
  • Willing to attend up to two BfitBwell exercise sessions (one in person supervised, one virtual unsupervised) per week for first 12 weeks then once monthly supervised and once weekly unsupervised virtual sessions for second 12 weeks
  • Not meeting dietary guidelines [i.e., Healthy Eating Index (HEI) score <80 as assessed via NCI DHQ III food frequency questionnaire] or physical activity guidelines [i.e., <150 minutes moderate/vigorous activity per week via self-report on Godin-Shephard Leisure-Time Physical Activity Questionnaire] (exceptions may be made at the discretion of the study PI on a case-by-case basis for highly motivated subjects)

Who cannot join

  • Eastern Cooperative Oncology Group (ECOG) Performance Status 2 or higher
  • Actively undergoing chemotherapy, radiation, immunotherapy with curative intent or within 3 months of completion of surgery, chemotherapy, or radiation treatment or recent initiation of targeted/hormonal therapy (<3 months) or maintenance therapy (<1 year) unless well-tolerated and deemed acceptable by PI on a case-by-case basis
  • Greater than 10 years post-active or maintenance therapy
  • Plans to relocate within the next 6 months
  • Plans for extended travel (>2 weeks) within the next 6 months
  • For females: (1) Currently pregnant or lactating, (2) Pregnant within the past 6 months, (3) Planning to become pregnant in the next 18 months; sexually active women of childbearing potential may be enrolled if they have had a tubal ligation or use a reliable means of contraception
Show all 29Show fewer
  • Any major surgery within the past 3 months or planned elective surgery during the intervention period, including mastectomy
  • Have completed treatment that significantly impacts digestion, metabolism, and/or food intake (e.g., surgical loss of esophagus, stomach, colon)
  • Recent (past 6 months) acute coronary event, unstable angina, coronary revascularization, stroke, or pulmonary embolism
  • Symptoms suggestive of cardiovascular disease (e.g., chest pain, shortness of breath at rest or with mild exertion, lightheadedness, syncope)
  • Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHg, systolic blood pressure >160 mmHg, or resting heart rate >100 bpm as measured in duplicate on the screening visit after 5 minutes of rest in a seated position (if screening is needed due to lack of updated medical record within previous 12 months)
  • Diabetes (history of type 1 or type 2 diabetes, hemoglobin A1c ≥6.5%, or fasting glucose ≥126 mg/dL as measured during the screening visit if screening is needed due to lack of updated medical record within previous 12 months) unless well controlled on metformin or DPP-V inhibitor monotherapy with hemoglobin A1c <8%
  • History of uncontrolled thyroid disorder. History of thyroid disease or current thyroid disease treated with a stable medication regimen is acceptable
  • Triglycerides >500 mg/dL as measured on the screening visit (if screening is needed due to lack of updated medical record within previous 12 months)
  • LDL cholesterol >200 mg/dL as measured on the screening visit (if screening is needed due to lack of updated medical record within previous 12 months)
  • Presence or history of other metabolic or chronic health problems which would impact ability to safely participate in a weight loss intervention involving diet and exercise: significant cardiac arrhythmias or cardiac valvular disease, significant gastrointestinal, pulmonary, renal, musculoskeletal, neurologic, hematologic, or psychiatric disease
  • Have started lipid-lowering, hypertension, or oral hypoglycemic medication in previous 3 months
  • Sustained use of prescription or over-the-counter medications known to significantly impact appetite, weight, or energy metabolism (e.g., obesity pharmacotherapeutics agents, appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants) with the exception of anti-endocrine or Her2 directed treatment for breast cancer and standard of care anti-emetic or anti-diarrheal agents.
  • Sustained use of systemic glucocorticoids (current or in the past 6 months) unless physiologic replacement therapy for adrenal insufficiency
  • Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed >1 year before screening, (2) lap banding if the band has been removed >1 year before screening, (3) intragastric balloon if the balloon has been removed >1 year before screening, (4) duodenal-jejunal bypass sleeve if the sleeve has been removed >1 year before screening, or (5) AspireAssist or other endoscopically placed weight loss device if the device has been removed >1 year before screening
  • Participation within previous 6 months, current participation in, or planning to participate in any formal nutrition, weight loss, or physical activity programs or clinical trials over the next 6 months
  • Previous participation the BfitBwell exercise oncology program within the previous 3 years (exceptions may be made at the discretion of the study PI)
  • Nicotine or tobacco use (current or past 6 months)
  • Current alcohol or substance abuse as assessed by the Cut down, Annoyed, Guilty, and Eye-Opener (CAGE) questionnaire (note: study PI will follow up if screener raises any concerns of substance abuse to determine final eligibility)
  • History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire of Eating and Weight Patterns (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the study MD to determine if it is appropriate for the subject to participate in the study
  • Current severe depression or history of severe depression within the previous year, based on Center for Epidemiologic Studies Depression Scale (CES-D) which in the opinion of the study MD would interfere with ability to adhere to the diet and exercise interventions and provide feedback on the interventions via questionnaires and focus groups
  • History of other significant psychiatric illness (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the study MD would interfere with ability to adhere to the diet and exercise interventions and provide feedback on the interventions via questionnaires and focus groups
  • Have medical or physical limitations or contraindications to engaging in physical activity (e.g., severe orthopedic conditions, paralysis) or are considered high-risk based on ACSM guidelines
  • Are cognitively unable to consent

Trial locations and contacts

1 site in 1 country.

United States1 site

  • University of Colorado Cancer Center

    Aurora, Colorado, 80045

Other trials in United States

About this study

Official title: BfedBwell INSPIRE: Impact of an Integrated Nutrition and Exercise Program for Post-treatment Survivors on Sleep Quality, Perceived Stress, and Biomarkers of Immune Dysregulation

This single-arm pilot study will evaluate the feasibility and acceptability of a comprehensive survivorship lifestyle intervention addressing nutrition, exercise, sleep health, and stress management. The intervention integrates the BfedBwell survivorship nutrition program with the BfitBwell clinical exercise oncology program. The augmented BfedBwell program includes: (1) a core education curriculum, (2) 1:1 counseling with a registered dietitian, (3) behavioral skills development, (4) group support, and (5) commercially available wearable technology and smart scales for self-monitoring of physical activity, sleep, and body weight.

Read the detailed description

Cancer survivors with overweight/obesity who have completed active treatment will be recruited from the University of Colorado Anschutz Medical Campus for participation in a 6-month single-arm study of the augmented BfedBwell + BfitBwell interventions. Feasibility and acceptability of integrating commercially-available wearable technology and smart scales will be evaluated. The study will also explore preliminary changes in sleep quality, perceived stress, and physiological indicators of stress and immune function.

Being tested
BfedBwell - Core Curriculum, BfedBwell - 1:1 Counseling, BfedBwell - Behavioral Skills, BfedBwell - Group Support, BfedBwell - Technology
Keywords
Adult Cancer Survivor, Lifestyle Behavior, Diet, food, and nutrition, Exercise, Sleep, Stress
Medical subject headings
Overweight, Obesity, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BfedBwell - Core CurriculumBehavioural

    Group-based education sessions based upon guidelines for nutrition and lifestyle behaviors for cancer survivorship

  • BfedBwell - 1:1 CounselingBehavioural

    Individual 1:1 counseling sessions with a registered dietitian to review progress and address barriers

  • BfedBwell - Behavioral SkillsBehavioural

    Group-based behavioral skills development sessions and cooking demonstrations to focus on behavior change techniques (e.g., self-monitoring, goal setting) and nutrition skills (e.g., recipe development, label reading)

  • BfedBwell - Group SupportBehavioural

    Structured group support sessions to share experiences

  • BfedBwell - TechnologyBehavioural

    Commercially available devices (fitness trackers, smart scales) for self-monitoring of physical activity, sleep, and body weight

  • BfitBwell - Clinical Exercise ProgramBehavioural

    Supervised exercise program developed by a cancer exercise specialist and based upon the NCCN guidelines for physical activity during cancer survivorship and other recommendations

Study groups in NCT07446595
Study groupRoleWhat they receive
BfedBwell INSPIRE InterventionExperimentalParticipants will receive a 6-month comprehensive survivorship lifestyle intervention combining nutrition education and counseling with structured exercise programming. The nutrition program includes a core curriculum, 1:1 counseling, behavioral skills, group support, and the use of wearable and remote monitoring devices to support self-monitoring of physical activity, sleep, and body weight.
Receives: Behavioral: BfedBwell - Core Curriculum; Behavioral: BfedBwell - 1:1 Counseling; Behavioral: BfedBwell - Behavioral Skills; Behavioral: BfedBwell - Group Support; Behavioral: BfedBwell - Technology; Behavioral: BfitBwell - Clinical Exercise Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determine the research protocol recruitment feasibility of the augmented BfedBwell nutrition intervention

    Recruitment will be assessed as the number of adults screened and the proportion of eligible screens who enroll

    Measured: 24 weeks

  2. Determine the research protocol adherence feasibility of the augmented BfedBwell nutrition intervention

    Adherence will be assessed as [# sessions attended/# sessions provided]

    Measured: 24 weeks

  3. Determine the research protocol outcome assessment feasibility of the augmented BfedBwell nutrition intervention

    Outcome assessment rates will be assessed as [# completing assessments/# enrolled]

    Measured: 24 weeks

  4. Determine the research protocol retention feasibility of the augmented BfedBwell nutrition intervention

    Retention will be assessed as [# of participants who complete the 24-week intervention/# of participants enrolled]

    Measured: 24 weeks

  5. Determine the intervention acceptability by participants during focus groups

    Participants will be asked to participate in a 90-minute focus group to provide qualitative feedback regarding their experience and satisfaction with the intervention.

    Measured: 24 weeks

  6. Determine the intervention acceptability by participants using the Net Promoter Score (NPS)

    Participants will be asked to complete weekly ratings using the Net Promoter Score (NPS). Respondents are grouped as follows: 1) promoters (score 9-10) are loyal enthusiasts who will keep referring others and fueling growth, 2) passives (score 7-8) are satisfied but unenthusiastic customers who are vulnerable to competitive offerings, and 3) detractors (score 0-6) are unhappy customers who can impede growth with negative word-of-mouth. The final NPS score is calculated as % promoters - % detractors. NPS scores range from -100 to +100, with scores >/=0 indicating good acceptability.

    Measured: 12 and 24 weeks

Secondary outcomes (2)

  1. Measure changes in self-reported sleep quality

    Participants will complete the Pittsburgh Sleep Quality Index (PSQI) to evaluate perceived sleep quality. The PSQI contains 19 self-rated questions assessing several factors relating to sleep quality, and the resulting global score ranges from 0-21 points. Higher scores indicate worse sleep quality.

    Measured: Baseline and 12 and 24 weeks

  2. Measure changes in perceived stress

    Participants will complete the Perceived Stress Scale (PSS) to assess self-reported psychological stress. The PSS contains 10 questions assessing perceived stress, and the resulting total score ranges from 0-40 points. Higher scores indicate greater perceived stress.

    Measured: Baseline and 12 and 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2026
  2. Study start11 Aug 2026
  3. Primary completionMar 2027 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07446595
Sponsor's protocol ID
26-0077.cc
Other IDs
IRC_FULL_2025_004, NCI-2026-02279
Status last verified
Aug 2026
First submitted
25 Feb 2026
Last updated
3 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing BfedBwell - Core Curriculum, BfedBwell - 1:1 Counseling and BfedBwell - Behavioral Skills in people with Cancer Survivorship and Overweight , Obesity, run by University of Colorado, Denver at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 29 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determine the research protocol recruitment feasibility of the augmented BfedBwell nutrition intervention (time frame: 24 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07446595.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in